These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 34601960)
1. Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease. Jia G; Sowers JR Hypertension; 2021 Nov; 78(5):1197-1205. PubMed ID: 34601960 [TBL] [Abstract][Full Text] [Related]
2. [Hypertension and diabetes]. Krzesinski JM; Weekers L Rev Med Liege; 2005; 60(5-6):572-7. PubMed ID: 16041861 [TBL] [Abstract][Full Text] [Related]
3. Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance. Masuo K; Rakugi H; Ogihara T; Esler MD; Lambert GW Curr Diabetes Rev; 2010 Mar; 6(2):58-67. PubMed ID: 20034369 [TBL] [Abstract][Full Text] [Related]
4. Treatment of hypertension in patients with diabetes. Sowers JR Arch Intern Med; 2004 Sep; 164(17):1850-7. PubMed ID: 15451759 [TBL] [Abstract][Full Text] [Related]
5. [Hypertension, microalbuminuria and insulin resistance in diabetes mellitus]. Bretzel RG Wien Klin Wochenschr; 1994; 106(24):774-92. PubMed ID: 7846897 [TBL] [Abstract][Full Text] [Related]
6. Insulin and blood pressure regulation. Gans RO; Donker AJ J Intern Med Suppl; 1991; 735():49-64. PubMed ID: 2043223 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of vascular disease in hypertension with special reference to diabetes. Yudkin JS Semin Vasc Med; 2002 May; 2(2):139-48. PubMed ID: 16222605 [TBL] [Abstract][Full Text] [Related]
8. Diabetic Vasculopathy: Molecular Mechanisms and Clinical Insights. Jia G; Bai H; Mather B; Hill MA; Jia G; Sowers JR Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255878 [TBL] [Abstract][Full Text] [Related]
9. SGLT2 Inhibitors and the Diabetic Kidney. Fioretto P; Zambon A; Rossato M; Busetto L; Vettor R Diabetes Care; 2016 Aug; 39 Suppl 2():S165-71. PubMed ID: 27440829 [TBL] [Abstract][Full Text] [Related]
10. Sympathetic nervous system, diabetes, and hypertension. Perin PC; Maule S; Quadri R Clin Exp Hypertens; 2001; 23(1-2):45-55. PubMed ID: 11270588 [TBL] [Abstract][Full Text] [Related]
11. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. Cooper SA; Whaley-Connell A; Habibi J; Wei Y; Lastra G; Manrique C; Stas S; Sowers JR Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2009-23. PubMed ID: 17586614 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular disease risk in youth with diabetes mellitus. Wadwa RP Rev Endocr Metab Disord; 2006 Sep; 7(3):197-204. PubMed ID: 17160723 [TBL] [Abstract][Full Text] [Related]
13. Insulin resistance and hypertension. Patients in double jeopardy for cardiovascular disease. McLaughlin T; Reaven G Geriatrics; 2000 Jun; 55(6):28-32, 35. PubMed ID: 10872343 [TBL] [Abstract][Full Text] [Related]
14. Insulin and insulin resistance: impact on blood pressure and cardiovascular disease. Sowers JR; Frohlich ED Med Clin North Am; 2004 Jan; 88(1):63-82. PubMed ID: 14871051 [TBL] [Abstract][Full Text] [Related]
15. Oxidative stress in insulin-resistant conditions: cardiovascular implications. Stump CS; Clark SE; Sowers JR Treat Endocrinol; 2005; 4(6):343-51. PubMed ID: 16318400 [TBL] [Abstract][Full Text] [Related]
16. The causes of raised blood pressure in insulin-dependent and non-insulin-dependent diabetes. Ferriss JB J Hum Hypertens; 1991 Aug; 5(4):245-54. PubMed ID: 1956022 [TBL] [Abstract][Full Text] [Related]
17. [Modifications of structural and functional properties of large arteries in diabetes mellitus]. Bortolotto LA Arq Bras Endocrinol Metabol; 2007 Mar; 51(2):176-84. PubMed ID: 17505624 [TBL] [Abstract][Full Text] [Related]
18. Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease? Bender SB; McGraw AP; Jaffe IZ; Sowers JR Diabetes; 2013 Feb; 62(2):313-9. PubMed ID: 23349535 [TBL] [Abstract][Full Text] [Related]